Periocular Cutaneous Malignancies: A Review of the Literature
Authors:
- Jordan B. SlutskyJSJordan B. Slutsky
- Evan C. JonesEJEvan C. Jones
- 1 April 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 38 (4) , 552-569
Abstract
The periocular skin is susceptible to numerous benign and malignant neoplasms. Periocular malignancies may present differently, behave more aggressively, and pose greater challenges for treatment and repair than malignancies at other cutaneous sites. Between 5% and 10% of cutaneous malignancies occur periorbitally, with basal cell carcinoma reported as the most common malignant periocular tumor, followed by squamous cell carcinoma, sebaceous gland carcinoma, cutaneous melanoma, Merkel cell carcinoma, and other rare tumors. To review the current literature on cutaneous malignancies of the periocular region pertaining to etiology, incidence, clinical presentation, differential diagnosis, complications, and treatment options. An extensive literature review was conducted using PubMed, searching for articles on periocular and periorbital cutaneous malignancies. Timely diagnosis and management of periocular malignancies is essential because of their proximity to and potential to invade vital structures such as the orbit, sinuses, and brain. Surgical excision remains the standard of care for the majority of periorbital malignancies, but given the sensitive anatomic location, tissue-sparing techniques with margin control such as Mohs micrographic surgery are the preferred method for most nonmelanoma skin cancers. Depending on tumor type, other treatment modalities may include radiation, chemotherapy, cryosurgery, topical medications, and photodynamic therapy.Keywords
This publication has 183 references indexed in Scilit:
- A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristicsJournal of the American Academy of Dermatology, 2011
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2009
- A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemptionJournal of the American Academy of Dermatology, 2009
- Immunotherapy With Imiquimod 5% Cream for Eyelid Nodular Basal Cell CarcinomaAmerican Journal of Ophthalmology, 2005
- Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005
- Treatment options and future prospects for the management of eyelid malignancies An evidence-based updateOphthalmology, 2001
- Sebaceous carcinomaJournal of the American Academy of Dermatology, 1995
- Malignant melanoma of the eyelidJournal of the American Academy of Dermatology, 1992
- Sebaceous carcinoma of the eyelid treated with Mohs' surgeryJournal of the American Academy of Dermatology, 1986
- Sebaceous carcinoma of the eyelid following radiation therapyAmerican Journal of Surgical Pathology, 1978